Serological Assays for Infectious Diseases
EUROIMMUN offers an extensive portfolio of ELISAs and ChLIAs for detection of antibodies against infectious agents. Examples include SARS-CoV-2, measles, mumps, rubella, varicella zoster, parvovirus B19, Epstein-Barr, TBE, dengue, chikungunya, Zika, Mayaro, West Nile and Crimean-Congo fever viruses, Bordetella pertussis, Borrelia, Chlamydia, Leishmania, Plasmodium, Trypanosoma and many more. All assays are fully automatable.
Easy to use, reliable and excellent results.
Immunology anti Sars-Cov-2 IgG anti S1 detection and quantification
It allows a good evaluation of the humoral immune response in seroprevalence studies and those related to the development of vaccines based on spike proteins. The assay also shows an excellent correlation with the current WHO Standard.
Review Date: 7 Apr 2021 | EUROIMMUN
- Serological diagnostics for an extensive range of respiratory, gastrointestinal, tick-borne, vaccine-preventable, sexually transmitted, pregnancy-related and emerging infectious diseases
- Sensitive and specific detection of IgG or IgM antibodies to support acute diagnostics and assessment of individual immune status.
- Optimal detection substrates, including many enhanced antigens developed at EUROIMMUN
- Standardized incubation conditions for efficient parallel analyses
- CSF formats to support diagnosis of central nervous system infections
- Avidity assays for differentiation of acute from past infections
- Flexible automation options for all throughput requirements